Addressing opioid overdose deaths: The vision for the HEALing communities study
Redonna K Chandler1, Jennifer Villani1, Thomas Clarke2
1National Institute on Drug Abuse, National Institutes of Health, 3WFN, 301 North Stonestreet Ave, Bethesda, MD, 20892, United States.
Drug and Alcohol Dependence
|October 19, 2020
Summary
The HEALing Communities Study (HCS) aims to cut opioid overdose deaths by 40% using evidence-based practices. This large-scale study integrates addiction treatment across healthcare and community settings, even amid the COVID-19 pandemic.
Area of Science:
- Addiction research
- Public health
- Implementation science
Background:
- The United States faces concurrent opioid and COVID-19 public health crises.
- The HEALing Communities Study (HCS) launched in May 2019, funded by NIH and SAMHSA.
- HCS is part of the Helping to End Addiction Long-termSM Initiative.
Purpose of the Study:
- To reduce opioid overdose deaths by 40% within three years.
- To enhance and integrate evidence-based practices (EBPs) for opioid use disorder.
- To implement EBPs across healthcare, justice, and community settings.
Main Methods:
- Large-scale implementation study design.
- Integration of multiple EBPs for opioid overdose prevention.
- Multi-setting approach (healthcare, justice, community).
Main Results:
- Study initiated pre-COVID-19, adapting to pandemic challenges.
- Focus on knowledge generation at the intersection of opioid epidemic and COVID-19.
- Potential to inform future public health interventions.
Conclusions:
- HCS is a significant initiative addressing the opioid crisis.
- The study's adaptability to COVID-19 is crucial.
- Findings will offer insights into managing co-occurring public health emergencies.
Keywords:
Evidence-based practicesHEALing communities studyHelping to End Addiction Long-termImplementationMedications for opioid use disorderOpioid use disorderOverdoseMore Related Videos
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.4K
08:53Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community
Published on: May 31, 2019
5.5K
Related Concept Videos
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
646
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
646
01:25Analgesia and Pain Management
1.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.3K
01:22Opioid Receptors: Overview
3.4K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.4K
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
740
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
740
01:17Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
494
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
494
01:24Substance Use Disorders Affecting Sleep
305
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
305